Correlation Between Sonnet Biotherapeutics and Regen BioPharma
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Regen BioPharma, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Regen BioPharma.
Diversification Opportunities for Sonnet Biotherapeutics and Regen BioPharma
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Sonnet and Regen is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Regen BioPharma go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Regen BioPharma
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to under-perform the Regen BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Sonnet Biotherapeutics Holdings is 8.15 times less risky than Regen BioPharma. The stock trades about -0.16 of its potential returns per unit of risk. The Regen BioPharma is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 57.00 in Regen BioPharma on September 1, 2024 and sell it today you would lose (48.96) from holding Regen BioPharma or give up 85.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.21% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Regen BioPharma
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Regen BioPharma |
Sonnet Biotherapeutics and Regen BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Regen BioPharma
The main advantage of trading using opposite Sonnet Biotherapeutics and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.| Sonnet Biotherapeutics vs. Tff Pharmaceuticals | Sonnet Biotherapeutics vs. Eliem Therapeutics | Sonnet Biotherapeutics vs. Inhibrx | Sonnet Biotherapeutics vs. Enliven Therapeutics |
| Regen BioPharma vs. Therapeutic Solutions International | Regen BioPharma vs. Alpha Cognition | Regen BioPharma vs. Regen BioPharma | Regen BioPharma vs. Vg Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |